English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The relation between plasma lipoproteins and atherosclerosis has evolved over the past fifty years. Serum cholesterol levels were shown to be associated with coronary artery disease (CAD) in familial hypercholesterolemia in the early 20th century (see Frederickson1). This cholesterol was determined to be in a particular lipoprotein class2 now termed low-density lipoprotein (LDL) cholesterol.3 LDL cholesterol has been shown to predict premature CAD in many studies,4 and a reduction in LDL cholesterol with statin therapy has been shown to decrease CAD events by up to 50% in primary5 and in secondary6 intervention trials. The National Cholesterol Education Program Adult Treatment Panel7 initially based recommendations for therapy to prevent CAD on LDL cholesterol levels. Later the measurement of HDL cholesterol was added to estimate risk.8See page 553 Because treatment for LDL cholesterol levels only decreases the risk for premature CAD by about half, other lipoprotein factors have been sought to explain the …

Increased ApoB in Small Dense LDL Particles Predicts Premature Coronary Artery Disease